Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sofocure
- Development stage
- Phase 4
- Lead developer
- Batterjee Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sofocure is an oral, small molecule nucleotide analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase. It is a generic formulation of sofosbuvir, originally developed by Gilead Sciences and marketed by Batterjee Pharma and Emcure Pharmaceuticals. Sofocure acts as a prodrug that is intracellularly metabolized into the active uridine analog triphosphate (GS-461203). This metabolite competes with natural nucleotides for incorporation into the viral RNA strand by the NS5B polymerase, resulting in premature chain termination and the cessation of viral replication. It is indicated for the treatment of chronic hepatitis C virus infection, typically administered as a 400 mg once-daily tablet in combination with other antiviral agents such as ribavirin or pegylated interferon.
- Brand names
- Sofocure
- Other names
- sofosbuvir
02
Targets
NS5B (Hepatitis C virus non-structural protein 5B (NS5B) RNA-dependent RNA polymerase)
Beyond the preview
Go deeper on Sofocure.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sofocure.